Stock-Based Compensation and Employee Benefit Plans (Details) (USD $)	12 Months Ended								12 Months Ended																								12 Months Ended					12 Months Ended					12 Months Ended		3 Months Ended	12 Months Ended				3 Months Ended	12 Months Ended
	Jun. 29, 2014	Jun. 30, 2013	Jun. 24, 2012	Jun. 29, 2014 Exercise Prices Per Share - Range 1 [Member]	Jun. 29, 2014 Exercise Prices Per Share - Range 2 [Member]	Jun. 29, 2014 Exercise Prices Per Share - Range 3 [Member]	Jun. 29, 2014 Exercise Prices Per Share - Range 4 [Member]	Jun. 29, 2014 Amended ESPP [Member]	Jun. 29, 2014 Granted to Employees [Member]	Jun. 29, 2014 Granted to Members of the Board of Directors [Member]	Jun. 29, 2014 Europe [Member]	Jun. 30, 2013 Europe [Member]	Jun. 24, 2012 Europe [Member]	Jun. 29, 2014 Asia [Member]	Jun. 30, 2013 Asia [Member]	Jun. 24, 2012 Asia [Member]	Jun. 29, 2014 United States [Member]	Jun. 30, 2013 United States [Member]	Jun. 24, 2012 United States [Member]	Jun. 29, 2014 General and Administrative Expense [Member]	Jun. 30, 2013 General and Administrative Expense [Member]	Jun. 24, 2012 General and Administrative Expense [Member]	Jun. 29, 2014 Research and Development Expense [Member]	Jun. 30, 2013 Research and Development Expense [Member]	Jun. 24, 2012 Research and Development Expense [Member]	Jun. 29, 2014 Cost of Sales [Member]	Jun. 30, 2013 Cost of Sales [Member]	Jun. 24, 2012 Cost of Sales [Member]	Jun. 29, 2014 Measured at Fair Value on a Recurring Basis [Member]	Jun. 30, 2013 Measured at Fair Value on a Recurring Basis [Member]	Jun. 29, 2014 Measured at Fair Value on a Recurring Basis [Member] Level 1 [Member]	Jun. 30, 2013 Measured at Fair Value on a Recurring Basis [Member] Level 1 [Member]	Jun. 29, 2014 Stock Compensation Plan [Member]	Jun. 29, 2014 Employee Stock Option [Member]	Jun. 30, 2013 Employee Stock Option [Member]	Jun. 24, 2012 Employee Stock Option [Member]	Jun. 27, 2010 Employee Stock Option [Member]	Jun. 29, 2014 Employee Stock Option [Member] Granted to Employees [Member]	Jun. 29, 2014 Restricted Stock Units (RSUs) [Member]	Jun. 30, 2013 Restricted Stock Units (RSUs) [Member]	Jun. 24, 2012 Restricted Stock Units (RSUs) [Member]	Jun. 27, 2010 Restricted Stock Units (RSUs) [Member]	Jun. 29, 2014 Restricted Stock Units (RSUs) [Member] Granted to Employees [Member]	Jun. 29, 2014 Restricted Stock Units (RSUs) [Member] Granted to Members of the Board of Directors [Member]	Sep. 25, 2011 Restricted Stock Units (RSUs) [Member] Granted to Executives and Certain Key Employees [Member]	Jun. 30, 2013 Restricted Stock Units (RSUs) [Member] Granted to Executives and Certain Key Employees [Member]	Jun. 29, 2014 Restricted Stock Units with Market Based Vesting Criteria [Member]	Jun. 30, 2013 Restricted Stock Units with Market Based Vesting Criteria [Member]	Jun. 24, 2012 Restricted Stock Units with Market Based Vesting Criteria [Member]	Jun. 30, 2013 Restricted Stock Units with Market Based Vesting Criteria [Member] Granted to Executives and Certain Key Employees [Member]	Jun. 29, 2014 Restricted Stock Units with Market Based Vesting Criteria [Member] Granted to Executives and Certain Key Employees [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting rights of awards granted																																						equal installments over each of the first three anniversaries of the date of grant, and expire after five years					equal installments over each of the first three anniversaries of the date of grant	on the first anniversary of the date of grant							These market-based RSU awards could potentially vest in any or each of the three consecutive quarters beginning with the final quarter of fiscal year 2017. The actual number of awards that will ultimately vest in each of the three quarters is based on the average closing price of the Company's common stock for that quarter, and in no event can the total number of shares vested in all three quarters exceed the total number of shares designated in the market-based RSU awards granted. Any of these awards that remain unvested as of the end of the second quarter of fiscal year 2018 will be forfeited.
Description of shares issued in respect of any 'full-value award'																																	Each share issued for a “full-value award” is counted against the share limit under the 2011 Plan as 1.50 shares for every one share actually issued in connection with the award.  For this purpose, a “full-value award” means any award other than a stock option or stock appreciation right.
Stock option shares activity [Roll Forward]
Outstanding, beginning of period (in shares)																																		1,187,000	2,044,000		2,992,000
Granted (in shares)																																		16,000	115,000	51,000
Exercised (in shares)	(885,854)	(929,036)	(224,884)																															(886,000)	(929,000)	(225,000)
Expired or forfeited (in shares)																																		(43,000)	(43,000)	(774,000)
Outstanding, end of period (in shares)																																		274,000	1,187,000	2,044,000	2,992,000
Stock option activity, additional disclosures [Abstract]
Weighted average option exercise price, outstanding, beginning of period (in dollars per share)																																		$ 17.08	$ 16.76		$ 21.30
Weighted average option exercise price, granted (in dollars per share)																																		$ 24.90	$ 19.96	$ 21.76
Weighted average option exercise price, exercised (in dollars per share)																																		$ 15.97	$ 16.66	$ 14.54
Weighted average option exercise price, expired or forfeited (in dollars per share)																																		$ 14.90	$ 18.71	$ 35.29
Weighted average option exercise price, outstanding, end of period (in dollars per share)																																		$ 21.47	$ 17.08	$ 16.76	$ 21.30
Weighted average grant date fair value, granted (in dollars per share)																																		$ 6.72	$ 5.58	$ 6.82
Aggregate intrinsic value, outstanding, beginning of period																																		$ 4,978,000	$ 7,031,000		$ 22,154,000
Aggregate intrinsic value, exercised																																		7,702,000	3,678,000	1,481,000
Aggregate intrinsic value, outstanding, end of period	1,852,000																																	1,852,000	4,978,000	7,031,000	22,154,000
Proceeds received from the exercise of stock options	14,100,000	15,500,000	3,300,000
Tax benefit realized for the tax deductions from stock options exercised	200,000	0	1,700,000
Restricted Stock Unit Activity [Roll Forward]
Outstanding, beginning of period (in shares)																																							3,696,000	2,905,000		2,051,000
Granted (in shares)									1,105,259	43,704																													1,644,000	1,928,000	1,518,000									495,081
Vested (in shares)																																							(1,065,000)	(804,000)	(560,000)
Expired or forfeited (in shares)																																							(450,000)	(333,000)	(104,000)
Outstanding, end of period (in shares)																																							3,825,000	3,696,000	2,905,000	2,051,000
Restricted stock unit activity, additional disclosures [Abstract]
Weighted average grant date fair value per share, outstanding, beginning of period (in dollars per share)																																							$ 21.31	$ 21.72		$ 21.22
Weighted average grant date fair value per share, granted (in dollars per share)																																							$ 24.36	$ 20.77	$ 19.80
Weighted average grant date fair value per share, vested (in dollars per share)																																							$ 21.44	$ 21.80	$ 22.49
Weighted average grant date fair value per share, expired or forfeited (in dollars per share)																																							$ 15.22	$ 22.04	$ 23.84
Weighted average grant date fair value per share, outstanding, end of period (in dollars per share)																																							$ 19.26	$ 21.31	$ 21.72	$ 21.22
Aggregate intrinsic value, outstanding, beginning of period																																							77,394,000	57,932,000		53,501,000
Aggregate intrinsic value, vested																																							28,644,000	16,180,000	12,821,000
Aggregate intrinsic value, outstanding, end of period																																							105,791,000	77,394,000	57,932,000	53,501,000
Shares withheld to fund grantee income tax withholding obligations (in shares)																																							348,502	268,677	185,701
Compensation expense recognized																																													(1,300,000)	(1,100,000)
Additional information relating to stock-based compensation plans [Abstract]
Outstanding options exercisable (in shares)	175,000	1,039,000	1,749,000
Options and RSUs available for grant (in shares)	4,276,000	6,040,000	8,505,000
Total reserved common stock shares for stock option plans (in shares)	8,375,000	10,923,000	13,454,000
Compensation cost not yet recognized [Abstract]
Total compensation cost not yet recognized	62,800,000
Total compensation cost not yet recognized, period for recognition (including award made to CEO) (in years)																																		1 year 6 months 7 days					2 years 3 months 29 days
Weighted average assumptions [Abstract]
Method used																																		Black‑Scholes													Monte Carlo
Expected life (in years)																																		3 years 6 months	3 years 6 months	3 years 6 months											3 years 6 months	2 years 8 months 12 days	3 years
Risk free interest rate (in hundredths)																																		0.79%	0.39%	0.44%											1.08%	0.66%	0.41%
Volatility (in hundredths)																																		35.41%	37.56%	42.25%											34.70%	36.62%	36.61%
Dividend yield (in hundredths)																																		0.00%	0.00%	0.00%											0.00%	0.00%	0.00%
Number of unissued shares in the ESPP (in shares)								755,542
Range of Exercise Price per Share - lower limit (in dollars per share)				$ 15.82	$ 20.15	$ 24.39	$ 32.20
Range of Exercise Price per Share - upper limit (in dollars per share)				$ 19.19	$ 22.72	$ 32.07	$ 34.27
Outstanding [Abstract]
Number Outstanding (in shares)	274,000			92,000	141,000	17,000	24,000
Outstanding, Weighted Average Remaining Life (in years)	2 years 1 month 24 days			0 years 7 months 15 days	3 years 2 months 24 days	3 years 11 months 27 days	0 years 5 months 2 days
Outstanding, Weighted Average Exercise Price (in dollars per share)	$ 21.47			$ 18.66	$ 20.70	$ 25.80	$ 33.88
Outstanding, Aggregate Intrinsic Value	1,852,000																																	1,852,000	4,978,000	7,031,000	22,154,000
Exercisable [Abstract]
Number Exercisable (in shares)	175,000			88,000	60,000	3,000	24,000
Exercisable, Weighted Average Remaining Life (in years)	1 year 4 months 7 days			0 years 5 months 20 days	2 years 11 months 26 days	1 year 6 months	0 years 5 months 2 days
Exercisable, Weighted Average Exercise Price (in dollars per share)	$ 21.77			$ 18.72	$ 21.00	$ 28.93	$ 33.88
Exercisable, Aggregate Intrinsic Value	1,186,000
Stock-based compensation expense	26,494,000	21,560,000	16,141,000																	13,144,000	11,166,000	9,199,000	8,108,000	6,001,000	4,176,000	5,242,000	4,393,000	2,766,000
Deferred Compensation Arrangements [Abstract]
Fair value of the assets of deferred compensation plan																													10,534,000	9,472,000	10,534,000	9,472,000
Fair value of the liabilities of deferred compensation plan																													9,844,000	8,326,000	9,844,000	8,326,000
Net changes in fair value for deferred compensation plan recorded in other expense	200,000	100,000	300,000
Defined Contribution Plans [Abstract]
Company contributions to retirement plans											$ 2,300,000	$ 1,800,000	$ 1,900,000	$ 100,000	$ 100,000	$ 100,000	$ 2,500,000	$ 2,200,000	$ 2,400,000